Corcept Therapeutics | CORT - EPS Earnings Per Share


Corcept Therapeutics reported $0.2 in EPS Earnings Per Share for its fiscal quarter ending in December of 2025.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q1 Mar/2026 -0.11 0.17 May/06 2026
FY2025Q4 Dec/2025 0.20 0.38 0.26 Feb/24 2026
FY2025Q3 Sep/2025 0.16 0.17 0.41 Nov/04 2025
FY2025Q2 Jun/2025 0.29 0.38 0.32 Jul/31 2025
FY2025Q1 Mar/2025 0.17 0.15 0.25 May/05 2025




Eps Change Date
Acadia Pharmaceuticals USD 1.6 1.18 Dec/2025
Alaunos Therapeutics USD -0.53 0.07 Sep/2025
ANI Pharmaceuticals USD 2.33 0.29 Dec/2025
Ardelyx USD 0 0.08 Sep/2025
Assertio Holdings USD -0.03 0.01 Sep/2024
Aurora Cannabis CAD -1 0.73 Sep/2025
BioMarin Pharmaceutical USD 0.46 0.34 Dec/2025
Bristol-Myers Squibb USD 1.26 0.37 Dec/2025
Canopy Growth CAD -0.08 0.14 Sep/2025
Corcept Therapeutics USD 0.2 0.04 Dec/2025
Eli Lilly USD 7.54 0.52 Dec/2025
Esperion Therapeutics USD 0.26 0.42 Dec/2025
J&J USD 2.46 0.34 Dec/2025
Knight Therapeutics CAD 0.03 0.06 Sep/2025
Lexicon Pharmaceuticals USD -0.04 0.01 Dec/2025
Merck USD 2.04 0.54 Dec/2025
Nektar Therapeutics USD -0.18 0.07 Sep/2024
Novartis USD 2.04 0.38 Sep/2025
Novartis USD 2.02 0.04 Sep/2025
Omeros USD -1.12 0.37 Jun/2024
Pacira USD 0.06 0.64 Dec/2025
Pfizer USD 0.66 0.21 Dec/2025
Supernus Pharmaceuticals USD -0.07 0.73 Dec/2025
TG Therapeutics USD 0.14 2.29 Dec/2025